P2.01-22 ORCHARD: A Phase II Platform Study in Patients with Advanced NSCLC Who Have Progressed on First-Line Osimertinib Therapy
| Autor: | Yu, H. 1, Goldberg, S. 2, Le, X. 3, Piotrowska, Z. 4, Smith, P. 5, Mensi, I. 5, Kirova, B. 5, Chmielecki, J. 6, Li-Sucholeicki, X. 6, Szekeres, P. 5, Doughton, G. 5, Patel, G. 7, Jewsbury, P. 5, Riess, J. 8 |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology October 2019 14(10) Supplement:S647-S647 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|